Elutia (ELUT) Net Income towards Common Stockholders Growth (1y) (2020 - 2026)
Powered by 
Analysis
Elutia (ELUT) Net Income towards Common Stockholders Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 12.92% |
| 10 | Elutia | 34.94 Mn | 15.04 Mn | 1.45 Mn | 20.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.44% |
| Mar 31, 2026 | -89.91% |
| Dec 31, 2025 | -61.05% |
| Sep 30, 2025 | -462.51% |
| Jun 30, 2025 | 65.90% |
| Mar 31, 2025 | 78.14% |
| Dec 31, 2024 | 447.36% |
| Sep 30, 2024 | 110.95% |
| Jun 30, 2024 | -165.32% |
| Mar 31, 2024 | -83.97% |
| Dec 31, 2023 | -114.58% |
| Sep 30, 2023 | 11.62% |
| Jun 30, 2023 | -13.01% |
| Mar 31, 2023 | -20.03% |
| Dec 31, 2022 | 33.64% |
| Sep 30, 2022 | -32.62% |
| Jun 30, 2022 | -294.05% |
| Mar 31, 2022 | -60.82% |
| Dec 31, 2021 | -69.23% |
| Sep 30, 2021 | 18.80% |